Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

3.

The murine monoclonal antibody anti-cytokeratin CAM 5.2 is specific for intracellular cytokeratin 8, not cytokeratin 18.

Cheng WC, Hsu JD, Yao CC, Han CP.

J Thorac Cardiovasc Surg. 2010 Jun;139(6):1674-5; author reply 1675. doi: 10.1016/j.jtcvs.2009.12.053. No abstract available.

4.

Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18).

Han CP, Hsu JD, Koo CL, Yang SF.

Hum Pathol. 2010 Apr;41(4):616-7; author reply 617. doi: 10.1016/j.humpath.2010.01.001. No abstract available.

PMID:
20226963
5.

Anticytokeratin CAM5.2 is not synonymous with CK8/18 monoclonal antibody; and anticytokeratin CAM5.2 can be a marker for cytokeratin 8 but not for cytokeratin 18 and 19.

Han CP, Hsu JD, Li YJ.

Am J Surg Pathol. 2010 Apr;34(4):595; author reply 595-6, 596. doi: 10.1097/PAS.0b013e3181cfbfd9. No abstract available.

PMID:
20154593
6.

CAM5.2 (Becton Dickinson Biosciences) is not synonymous with CK8/18 (Leica Microsystems).

Wang KC, Hsu JD, Yao CC, Han CP.

Cytopathology. 2010 Aug;21(4):277-8; author reply 278. doi: 10.1111/j.1365-2303.2010.00743.x. Epub 2010 Mar 12. No abstract available.

PMID:
20345964
8.

Anti-cytokeratin CAM5.2 is not a monoclonal antibody against cytokeratin 8/18.

Hsu JD, Yao CC, Han LW, Han CP.

Clin Exp Dermatol. 2010 Aug;35(6):672-3. doi: 10.1111/j.1365-2230.2010.03814.x. Epub 2010 Mar 23. No abstract available.

PMID:
20337654
10.

BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.

Liao CL, Tzeng SL, Hsu JD, Chen PJ, Han CP.

Pathol Int. 2010 May;60(5):417; author reply 418. doi: 10.1111/j.1440-1827.2010.02531_1.x. No abstract available.

PMID:
20518894
11.
12.

Anticytokeratin CAM 5.2 does not correspond to antibodies CK 8/18.

Chao WR, Lin JC, Huang YC, Chen CK, Han CP.

Head Neck Pathol. 2013 Dec;7(4):398-9. doi: 10.1007/s12105-013-0469-5. Epub 2013 Jul 6. No abstract available.

13.
15.

Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation - report of a unique case.

Petersson F, Michal M, Franco M, Hes O.

Int J Clin Exp Pathol. 2010 May 5;3(5):534-40.

16.

Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.

Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B.

Eur Urol. 2000 Apr;37(4):484-7.

PMID:
10765081
17.
18.

[Case report on the immunocytochemical differential diagnosis of serous effusions and cyst fluids].

Ammon A, Graewe T.

Onkologie. 1987 Apr;10(2):97-8. German. No abstract available.

PMID:
2438614
19.

BD Pharmingen purified mouse anti-cytokeratin 7 monoclonal antibody (clone RCK105) should not be mistaken for BD Biosciences anti-cytokeratin CAM5.2 reagent (clone CAM 5.2).

Tseng CJ, Lin YH, Han CP.

Am J Obstet Gynecol. 2011 Jan;204(1):e14. doi: 10.1016/j.ajog.2010.08.062. Epub 2010 Oct 29. No abstract available.

PMID:
21035782
20.

Anti-Cytokeratin (CAM5.2) reagent directed against cytokeratin 8, not cytokeratin 18. Comment on "Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study. Eur J Surg Oncol. 2009; 35: 1065-1070.".

Lin CK, Yao CC, Tseng SW, Han CP.

Eur J Surg Oncol. 2010 Apr;36(4):428; author reply 429. doi: 10.1016/j.ejso.2010.01.003. Epub 2010 Feb 4. No abstract available.

PMID:
20133104

Supplemental Content

Support Center